NO20022021L - Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler - Google Patents

Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler

Info

Publication number
NO20022021L
NO20022021L NO20022021A NO20022021A NO20022021L NO 20022021 L NO20022021 L NO 20022021L NO 20022021 A NO20022021 A NO 20022021A NO 20022021 A NO20022021 A NO 20022021A NO 20022021 L NO20022021 L NO 20022021L
Authority
NO
Norway
Prior art keywords
alkyl
replaced
preparation
dihydrotiazole
benzocyclohepta
Prior art date
Application number
NO20022021A
Other languages
English (en)
Other versions
NO20022021D0 (no
NO322309B1 (no
Inventor
Gerhard Jaehne
Matthias Gossel
Hans-Jochen Lang
Martin Bickel
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2000113306 external-priority patent/DE10013306A1/de
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20022021L publication Critical patent/NO20022021L/no
Publication of NO20022021D0 publication Critical patent/NO20022021D0/no
Publication of NO322309B1 publication Critical patent/NO322309B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/428Thiazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Oppfinnelsen vedrører en forbindelse med formel (I). Y er en direkte binding, -CH-, -CH-CH-; X representerer CHCH(CH); CH(CH), CH(CH), CH(CH); R4 representerer (C-C)-cykloalkyl, hvori ett eller flere hydrogener kan substitueres i alkylgruppene med fluor eller et hydrogen kan erstattes med OH, OC(0)CH, OC(0)H, 0-CH-Ph eller 0-(C,-C)-alkyl;. (CH)-A-Rg, hvori n = 1 - 6, idet gruppen -CH-0-CH-fenyl, hvori fenyl er usubstituert, er utelatt; (CH)-B-R, hvori r = 1 - 6; A er O, S, SO, S0; B er NH, N-(C-C)-alkyl, NCHO, N(CO-CH); R8 representerer (C-C)-alkyl, (C-C)-cykloalkyl, idet i alkylgruppene ett eller flere hydrogener kan være erstattet med fluor eller et hydrogen kan være erstattet med OH, OC(0)CH, OC(0)H, 0-CH-Ph eller O-(C|-C)-alkyl; (CH)-aryl, hvor m = 0 - 6 og aryl er fenyl, naftyl, bifenyl, tienyl eller pyridyl og aryldelen kan være erstattet opp til to ganger og hvori gruppene Ri, R'i, Rog Rhar de angitte betydninger. Oppfinnelsen vedrører også fysiologisk tålbare salter av forbindelsene og fremgangsmåte for fremstilling av forbindelsene. Forbindelsene ifølge oppfinnelsen er f.eks. egnet for anvendelse som anorektiske midler.
NO20022021A 1999-11-05 2002-04-29 Indenotiazolforbindelser, legemiddel som inneholder slike forbindelser, fremgangsmate for deres fremstilling og deres anvendelse som anoreksimidler. NO322309B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19953205 1999-11-05
DE2000113306 DE10013306A1 (de) 2000-03-17 2000-03-17 Polycyclische, in 2-Stellung mit substituierten Alkylresten versehene Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
PCT/EP2000/010396 WO2001032638A1 (de) 1999-11-05 2000-10-21 Indeno-, naphtho- und benzocyclohepta-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel

Publications (3)

Publication Number Publication Date
NO20022021L true NO20022021L (no) 2002-04-29
NO20022021D0 NO20022021D0 (no) 2002-04-29
NO322309B1 NO322309B1 (no) 2006-09-11

Family

ID=26004890

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022021A NO322309B1 (no) 1999-11-05 2002-04-29 Indenotiazolforbindelser, legemiddel som inneholder slike forbindelser, fremgangsmate for deres fremstilling og deres anvendelse som anoreksimidler.

Country Status (27)

Country Link
US (1) US6387935B1 (no)
EP (1) EP1230230B1 (no)
JP (1) JP2003524632A (no)
KR (1) KR20020047331A (no)
CN (1) CN1176080C (no)
AR (1) AR026338A1 (no)
AT (1) ATE250045T1 (no)
AU (1) AU777569B2 (no)
BR (1) BR0015322A (no)
CA (1) CA2389703A1 (no)
CZ (1) CZ20021528A3 (no)
DE (1) DE50003761D1 (no)
DK (1) DK1230230T3 (no)
EE (1) EE200200235A (no)
ES (1) ES2206320T3 (no)
HK (1) HK1050524A1 (no)
HR (1) HRP20020379A2 (no)
HU (1) HUP0203290A3 (no)
IL (1) IL149400A0 (no)
MX (1) MXPA02003477A (no)
NO (1) NO322309B1 (no)
NZ (1) NZ518751A (no)
PL (1) PL354533A1 (no)
PT (1) PT1230230E (no)
SK (1) SK6132002A3 (no)
WO (1) WO2001032638A1 (no)
YU (1) YU29602A (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EP2305352A1 (en) 2004-04-02 2011-04-06 Merck Sharp & Dohme Corp. 5-alpha-reductase inhibitors for use in the treatment of men with metabolic and anthropometric disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
AU2008261102B2 (en) 2007-06-04 2013-11-28 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2930674A1 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011528375A (ja) 2008-07-16 2011-11-17 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
CN102264228A (zh) 2008-10-22 2011-11-30 默沙东公司 用于抗糖尿病药的新的环状苯并咪唑衍生物
AU2009309037A1 (en) 2008-10-31 2010-05-06 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
AU2011218830B2 (en) 2010-02-25 2014-07-24 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
ES2652662T3 (es) 2011-02-25 2018-02-05 Merck Sharp & Dohme Corp. Novedosos derivados de azabencimidazol cíclicos útiles como agentes antidiabéticos
CN108676076A (zh) 2011-03-01 2018-10-19 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
AU2013296470B2 (en) 2012-08-02 2016-03-17 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
MX2015010935A (es) 2013-02-22 2015-10-29 Merck Sharp & Dohme Compuestos biciclicos antidiabeticos.
WO2014139388A1 (en) 2013-03-14 2014-09-18 Merck Sharp & Dohme Corp. Novel indole derivatives useful as anti-diabetic agents
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法
WO2015051496A1 (en) 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
WO2018106518A1 (en) 2016-12-06 2018-06-14 Merck Sharp & Dohme Corp. Antidiabetic heterocyclic compounds
US10968232B2 (en) 2016-12-20 2021-04-06 Merck Sharp & Dohme Corp. Antidiabetic spirochroman compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507868A (en) * 1968-10-21 1970-04-21 Sandoz Ag Imidazo(2,1-b)thiazoles and thiazolo(3,2-a)pyrimidines
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19844547C2 (de) * 1998-09-29 2002-11-07 Aventis Pharma Gmbh Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908539A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Dihydrothiazolsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
ES2206320T3 (es) 2004-05-16
CA2389703A1 (en) 2001-05-10
PT1230230E (pt) 2003-12-31
KR20020047331A (ko) 2002-06-21
HUP0203290A3 (en) 2004-12-28
EP1230230A1 (de) 2002-08-14
JP2003524632A (ja) 2003-08-19
PL354533A1 (en) 2004-01-26
YU29602A (sh) 2006-01-16
AU1274601A (en) 2001-05-14
WO2001032638A1 (de) 2001-05-10
AU777569B2 (en) 2004-10-21
HUP0203290A2 (hu) 2003-01-28
CN1384827A (zh) 2002-12-11
NO20022021D0 (no) 2002-04-29
EP1230230B1 (de) 2003-09-17
CZ20021528A3 (cs) 2002-07-17
BR0015322A (pt) 2002-07-09
DK1230230T3 (da) 2003-12-15
EE200200235A (et) 2003-06-16
ATE250045T1 (de) 2003-10-15
NO322309B1 (no) 2006-09-11
IL149400A0 (en) 2002-11-10
US6387935B1 (en) 2002-05-14
NZ518751A (en) 2004-06-25
SK6132002A3 (en) 2002-11-06
CN1176080C (zh) 2004-11-17
DE50003761D1 (de) 2003-10-23
HK1050524A1 (en) 2003-06-27
MXPA02003477A (es) 2002-08-20
AR026338A1 (es) 2003-02-05
HRP20020379A2 (en) 2004-02-29

Similar Documents

Publication Publication Date Title
NO20022021L (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler
TW200724136A (en) Pharmaceutical compositions comprising PPAR modulator
NO331165B1 (no) Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter
ES8605806A1 (es) Procedimiento de preparacion de nuevos derivados de la xan- tina y de sus sales de adicion con acidos apropiados
MY147730A (en) Metabotropic glutamate receptor antagonists
WO2003057225A3 (en) Phosphate transport inhibitors
AR024969A1 (es) Derivados de 8-fenil-6,9-dihidro-[1,2,4]triazol[3,4-i]purin-5-ona
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
NO20022124L (no) Imidazopyridinderivater som fosfodiesterase VII-inhibitorer
EP0353955A3 (en) Novel compounds
ES2193746T3 (es) Acelerantes para sistemas reticulables.
BRPI0409049A (pt) métodos de preparação de um composto, composição e composição cristalina
WO2003089577A3 (en) Antihelminthic anthraquinones and method of use thereof
EA200100969A1 (ru) Новые соединения циклобутендиона, способ их получения и содержащие их фармацевтические композиции
DK1532098T3 (da) Fremgangsmåde til fremstilling af nitrooxyderivater af naproxen
WO2001079170A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
NO20003431L (no) Nye metalloproteaseinhibitorer, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
ATE95180T1 (de) Berbanderivate und ihre herstellung und pharmazeutische zubereitung.
SE8500964L (sv) Aminodiarylsulfoxidderivat, forfarande for framstellning derav och farmaceutiska och pesticidiska kompositioner innehallande desamma
NO20000054D0 (no) Polyhydroksyalkylpyrazinderivater, deres fremstilling og medisiner inneholdende forbindelsene
HK1058354A1 (en) Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
EA200100344A2 (ru) Новые циклобутаиндолкарбоксамидные производные, способ их получения и содержащие их фармацевтические композиции
ES528451A0 (es) Procedimiento de preparacion de un derivado 1,1-difenilpropan-1-ol
NO20022891L (no) Nye cykliske <alfa>-amino-<gamma>-hydroksyamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetningerinneholdende dem
FR2794122B1 (fr) Nouveaux antioxydants, procedes de preparation et utilisations